565 related articles for article (PubMed ID: 24561266)
1. TGFβ and matrix-regulated epithelial to mesenchymal transition.
Moustakas A; Heldin P
Biochim Biophys Acta; 2014 Aug; 1840(8):2621-34. PubMed ID: 24561266
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming during epithelial to mesenchymal transition under the control of TGFβ.
Tan EJ; Olsson AK; Moustakas A
Cell Adh Migr; 2015; 9(3):233-46. PubMed ID: 25482613
[TBL] [Abstract][Full Text] [Related]
3. Has2 natural antisense RNA and Hmga2 promote Has2 expression during TGFβ-induced EMT in breast cancer.
Kolliopoulos C; Lin CY; Heldin CH; Moustakas A; Heldin P
Matrix Biol; 2019 Jul; 80():29-45. PubMed ID: 30194979
[TBL] [Abstract][Full Text] [Related]
4. Efficient TGFβ-induced epithelial-mesenchymal transition depends on hyaluronan synthase HAS2.
Porsch H; Bernert B; Mehić M; Theocharis AD; Heldin CH; Heldin P
Oncogene; 2013 Sep; 32(37):4355-65. PubMed ID: 23108409
[TBL] [Abstract][Full Text] [Related]
5. Induction of epithelial-mesenchymal transition by transforming growth factor β.
Moustakas A; Heldin CH
Semin Cancer Biol; 2012 Oct; 22(5-6):446-54. PubMed ID: 22548724
[TBL] [Abstract][Full Text] [Related]
6. Extracellular Matrix Derived from High Metastatic Human Breast Cancer Triggers Epithelial-Mesenchymal Transition in Epithelial Breast Cancer Cells through αvβ3 Integrin.
M Brandão-Costa R; Helal-Neto E; M Vieira A; Barcellos-de-Souza P; Morgado-Diaz J; Barja-Fidalgo C
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32340328
[TBL] [Abstract][Full Text] [Related]
7. Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β.
Tsubakihara Y; Moustakas A
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463358
[TBL] [Abstract][Full Text] [Related]
8. HAS2 and CD44 in breast tumorigenesis.
Heldin P; Basu K; Kozlova I; Porsch H
Adv Cancer Res; 2014; 123():211-29. PubMed ID: 25081531
[TBL] [Abstract][Full Text] [Related]
9. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events.
Junk DJ; Cipriano R; Bryson BL; Gilmore HL; Jackson MW
Neoplasia; 2013 Sep; 15(9):1100-9. PubMed ID: 24027434
[TBL] [Abstract][Full Text] [Related]
11. SOX4 induces epithelial-mesenchymal transition and contributes to breast cancer progression.
Zhang J; Liang Q; Lei Y; Yao M; Li L; Gao X; Feng J; Zhang Y; Gao H; Liu DX; Lu J; Huang B
Cancer Res; 2012 Sep; 72(17):4597-608. PubMed ID: 22787120
[TBL] [Abstract][Full Text] [Related]
12. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
[TBL] [Abstract][Full Text] [Related]
13. TGF-β signaling and epithelial-mesenchymal transition in cancer progression.
Katsuno Y; Lamouille S; Derynck R
Curr Opin Oncol; 2013 Jan; 25(1):76-84. PubMed ID: 23197193
[TBL] [Abstract][Full Text] [Related]
14. USP11 Enhances TGFβ-Induced Epithelial-Mesenchymal Plasticity and Human Breast Cancer Metastasis.
Garcia DA; Baek C; Estrada MV; Tysl T; Bennett EJ; Yang J; Chang JT
Mol Cancer Res; 2018 Jul; 16(7):1172-1184. PubMed ID: 29724812
[TBL] [Abstract][Full Text] [Related]
15. Regulation of EMT by TGFβ in cancer.
Heldin CH; Vanlandewijck M; Moustakas A
FEBS Lett; 2012 Jul; 586(14):1959-70. PubMed ID: 22710176
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of hyaluronan synthase 2 in breast carcinoma and its biological significance.
Lien HC; Lee YH; Jeng YM; Lin CH; Lu YS; Yao YT
Histopathology; 2014 Sep; 65(3):328-39. PubMed ID: 24527698
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of gangliotetraosylceramide and β1,3-galactosyltransferase-4 gene expression by Smads during transforming growth factor β-induced epithelial-mesenchymal transition.
Guo J; Song B; Li X; Hε C; Yang G; Yang X; Guan F
Mol Med Rep; 2015 Mar; 11(3):2241-7. PubMed ID: 25384497
[TBL] [Abstract][Full Text] [Related]
18. Extracellular matrix as a contextual determinant of transforming growth factor-β signaling in epithelial-mesenchymal transition and in cancer.
Cichon MA; Radisky DC
Cell Adh Migr; 2014; 8(6):588-94. PubMed ID: 25482625
[TBL] [Abstract][Full Text] [Related]
19. Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT): from cancer stem cells to aging-associated fibrosis.
Cufí S; Vazquez-Martin A; Oliveras-Ferraros C; Martin-Castillo B; Joven J; Menendez JA
Cell Cycle; 2010 Nov; 9(22):4461-8. PubMed ID: 21088486
[TBL] [Abstract][Full Text] [Related]
20. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling.
Yeo SK; Wen J; Chen S; Guan JL
Cancer Res; 2016 Jun; 76(11):3397-410. PubMed ID: 27197172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
